查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1930072

全球灌注系统市场：市场规模、占有率、成长率、产业分析、依类型、应用和地区划分的分析及预测（2026-2034 年）

Perfusion Systems Market Size, Share, Growth and Global Industry Analysis By Type & Application, Regional Insights and Forecast to 2026-2034
出版日期: | 出版商: Fortune Business Insights Pvt. Ltd. | 英文 158 Pages | 商品交期: 请询问到货日

价格

灌注系统市场成长因子

由于慢性心血管和呼吸系统疾病的增加、器官移植手术的增多以及先进灌注技术的日益普及，全球灌注系统市场正经历强劲增长。根据 Fortune Business Insights 预测，该市场规模预计将在 2025 年达到 54.5 亿美元，从 2026 年的 59.7 亿美元增长到 2034 年的 147.7 亿美元，在预测期（2026-2034 年）内复合年增长率 (CAGR) 为 12.00%。

北美地区在 2025 年占灌注系统市场的主导地位，市占率为 39.50%。大量心肺手术、完善的医疗基础设施以及主要市场参与者的存在都为此提供了支持。

市场驱动因素

体外循环系统是一种医疗设备，可在受控环境中模拟器官的自然功能，在心臟手术、器官移植和体外循环手术中发挥关键作用。由于心血管疾病、慢性肺病和肾衰竭等非传染性疾病（NCDs）发病率的上升，全球体外循环手术的数量正在显着增加。

此外，人口老化加剧也是市场成长的主要驱动因素。例如，到2023年，中国65岁及以上人口将达到2.034亿，占总人口的14.3%，这将直接增加对先进外科手术和体外循环支持系统的需求。

市场趋势

机械灌注应用日益普及

影响市场的一个关键趋势是，人们越来越倾向于选择机械灌注，尤其是在器官保存方面。医疗机构和移植中心扩大采用低温和常温机械灌注技术，以提高器官存活率并降低移植后排斥反应率。

根据2023年移植受者科学登记数据，在DCD（临终捐赠）中采用机械灌注的比例显着提高，到2023年7月已达到约60%。这一趋势正在加速离体器官灌注系统的研究和发展。

市场区隔分析

依产品类型

依产品类型划分，市场可细分为心肺灌注系统、体外膜氧合（ECMO）及离体器官灌注系统。

  • 预计2026年，心肺灌注系统将占市场主导地位，市占率高达76.57%。这主要归功于心臟和肺部手术以及移植手术数量的激增。
  • 由于全球ECMO中心数量的不断增加，ECMO市场预计将稳定成长。
  • 由于研发投入的增加以及体外器官保存技术的应用，离体器官灌注系统预计将以最快的速度成长。

依年龄组别划分

  • 预计到2026年，成人市场将占58.42%的市场占有率，主要受心血管疾病和器官衰竭高发生率的推动。
  • 由于先天性心臟病和儿童器官移植手术的增加，预计儿科市场将以显着的复合年增长率增长。

依最终使用者划分

  • 预计到2026年，医院和门诊手术中心（ASC）将占市场主导地位，市场占有率达45.60%，主要得益于其高手术量和先进的基础设施。
  • 由于专业化程度的提高和临床研究活动的开展，专科诊所和研究机构预计将实现稳步增长。

区域概览

  • 北美：受心臟手术量增加和产品创新强劲的推动，预计到 2025 年，市场规模将达到 21.6 亿美元。美国市场预计到 2026 年将达到 22 亿美元。
  • 欧洲：德国和法国移植手术量的增加以及器官捐赠系统的改进，推动了市场成长。
  • 亚太地区：由于人口老化和慢性病负担加重，预计中国、日本和印度将实现最高的复合年增长率。
  • 拉丁美洲、中东和非洲：由于医疗基础设施的改善和公众意识提升活动的扩大，预计市场将实现温和成长。

目录

第一章：引言

第二章：摘要整理

第三章：市场动态

  • 市场驱动因素
  • 市场限制因素
  • 市场机遇
  • 市场趋势

第四章：关键考虑因素

  • 主要国家主要心血管疾病盛行率（2025 年）
  • 主要国家主要器官移植数量（2025 年）
  • 主要产品及主要国家价格分析
  • 主要公司新产品发布
  • 关键产业趋势：併购、业务伙伴关係
  • 新冠疫情对市场的影响

第五章 全球灌流系统市场分析：洞察与预测（2021-2034）

  • 市场分析、洞察与预测：依产品类型划分
    • 心肺灌注系统
      • 氧合系统
      • 体外循环机
      • 冷却加热设备
      • 血液参数监测系统
      • 离心式血液帮浦系统
      • 其他
    • 体外膜氧合（ECMO）
    • 离体器官灌注系统
  • 市场分析、洞察与预测：依年龄组别划分
    • 成人
    • 儿童
  • 市场分析，洞察与预测：依最终用户划分
    • 医院及门诊手术中心
    • 专科诊所
    • 其他
  • 市场分析、洞察与预测：依地区划分
    • 北美
    • 欧洲
    • 亚太地区
    • 拉丁美洲
    • 中东和非洲

第六章 北美灌流系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 美国
    • 加拿大

第七章 欧洲灌注系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 德国
    • 美国王国
    • 法国
    • 西班牙
    • 义大利
    • 斯堪的纳维亚
    • 其他欧洲国家

第八章 亚太灌注系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 日本
    • 中国
    • 印度
    • 澳大利亚
    • 东南亚
    • 亚太其他地区

第九章 拉丁美洲灌流系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 巴西
    • 墨西哥
    • 拉丁美洲其他地区

第十章 中东与非洲灌注系统市场分析：洞察与预测（2021-2034）

  • 依国家划分
    • 海湾合作委员会 (GCC) 国家
    • 南非
    • 中东和非洲其他地区

第11章 竞争分析

  • 世界市场占有率分析(2025年)
  • 企业简介
    • Cardinal Health
    • Terumo Corporation
    • Medtronic
    • NIPRO
    • LivaNova PLC
    • Getinge
    • XVIVO
    • MicroPort Scientific Corporation
    • TransMedics
    • ECM Europe BV
Product Code: FBI103497

Growth Factors of perfusion systems Market

The global perfusion systems market is experiencing robust growth due to the increasing prevalence of chronic cardiovascular and respiratory diseases, rising organ transplantation procedures, and growing adoption of technologically advanced perfusion technologies. According to Fortune Business Insights, the market was valued at USD 5.45 billion in 2025 and is projected to grow from USD 5.97 billion in 2026 to USD 14.77 billion by 2034, registering a CAGR of 12.00% during the forecast period (2026-2034).

North America dominated the perfusion systems market in 2025, accounting for a 39.50% market share, supported by a high volume of cardiopulmonary procedures, strong healthcare infrastructure, and the presence of leading market players.

Market Drivers

Perfusion systems are medical devices that replicate the natural functioning of organs in a controlled environment and play a critical role during cardiac surgeries, organ transplantation, and extracorporeal circulation procedures. The rising incidence of non-communicable diseases (NCDs) such as cardiovascular disease, chronic lung disorders, and kidney failure is significantly increasing the number of cardiopulmonary bypass procedures globally.

Additionally, the growing geriatric population is a key contributor to market growth. For instance, China's population aged 65 years reached 203.4 million in 2023, accounting for 14.3% of the total population, which is directly increasing the demand for advanced surgical interventions and perfusion support systems.

Market Trends

Increasing Adoption of Machine Perfusion

A key trend shaping the market is the shifting preference toward machine perfusion, particularly for organ preservation. Healthcare organizations and transplant centers are increasingly adopting hypothermic and normothermic machine perfusion techniques to improve organ viability and reduce post-transplant rejection rates.

According to the 2023 Scientific Registry of Transplant Recipients, the adoption of machine perfusion for donation after circulatory death (DCD) organs increased significantly, reaching around 60% by July 2023. This trend is accelerating research activities and product development in isolated organ perfusion systems.

Market Segmentation Analysis

By Product Type

Based on product type, the market is segmented into cardiopulmonary perfusion systems, extracorporeal membrane oxygenation (ECMO), and isolated organ perfusion systems.

  • Cardiopulmonary perfusion systems dominated the market in 2026, holding a 76.57% share, driven by the high volume of heart and lung surgeries and transplant procedures.
  • The ECMO segment is expected to grow steadily due to the rising number of ECMO centers worldwide.
  • Isolated organ perfusion systems are projected to grow at the fastest rate, supported by increasing R&D efforts and adoption of ex-vivo organ preservation technologies.

By Age Group

  • The adult segment accounted for 58.42% market share in 2026, driven by a high prevalence of cardiovascular disorders and organ failures.
  • The pediatric segment is expected to grow at a significant CAGR due to increasing congenital heart disorders and pediatric transplant procedures.

By End User

  • Hospitals & ASCs dominated the market in 2026 with a 45.60% share, owing to higher procedure volumes and availability of advanced infrastructure.
  • Specialty clinics and research institutes are expected to witness steady growth due to rising specialization and increased clinical research activities.

Regional Insights

  • North America: Valued at USD 2.16 billion in 2025, driven by rising cardiac surgeries and strong product innovation. The U.S. market is projected to reach USD 2.20 billion by 2026.
  • Europe: Growth supported by increasing transplant procedures in Germany and France and improving organ donation frameworks.
  • Asia Pacific: Expected to register the highest CAGR, driven by a growing elderly population and rising chronic disease burden in China, Japan, and India.
  • Latin America & Middle East & Africa: Moderate growth due to improving healthcare infrastructure and rising awareness initiatives.

Competitive Landscape

The market is semi-consolidated, with major players such as LivaNova PLC, Getinge, Medtronic, XVIVO, and TransMedics holding a significant share. These companies are focusing on product launches, regulatory approvals, and R&D investments to strengthen their global presence.

Conclusion

The global perfusion systems market is poised for strong growth through 2034, driven by rising cardiopulmonary procedures, increasing organ transplantation, and technological advancements in machine perfusion systems. With the market expected to reach USD 14.77 billion by 2034, continuous innovation, expanding healthcare access, and growing awareness of advanced perfusion technologies will remain key growth enablers. Despite cost-related challenges in emerging economies, sustained investments by key players and supportive government initiatives are expected to strengthen market adoption worldwide.

Segmentation By Product Type

  • Cardiopulmonary Perfusion Systems
    • Oxygenation Systems
    • Heart-Lung Machines
    • Cooling and Heating Devices
    • Blood Parameter Monitoring Systems
    • Centrifugal Blood Pump Systems
    • Others
  • Extracorporeal Membrane Oxygenation (ECMO)
  • Isolated Organ Perfusion Systems

By Age Group

  • Adults
  • Pediatrics

By End User

  • Hospitals & ASCs
  • Specialty Clinics
  • Others

By Region

  • North America (By Product Type, By Age Group, By End User, By Country)
    • U.S.
    • Canada
  • Europe (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • U.K.
    • Germany
    • France
    • Italy
    • Spain
    • Scandinavia
    • Rest of Europe
  • Asia Pacific (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • China
    • India
    • Japan
    • Australia
    • Southeast Asia
    • Rest of Asia Pacific
  • Latin America (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa (By Product Type, By Age Group, By End User, By Country/Sub-region)
    • GCC
    • South Africa
    • Rest of the Middle East & Africa

Table of Content

1. Introduction

  • 1.1. Research Scope
  • 1.2. Market Segmentation
  • 1.3. Research Methodology
  • 1.4. Definitions and Assumptions

2. Executive Summary

3. Market Dynamics

  • 3.1. Market Drivers
  • 3.2. Market Restraints
  • 3.3. Market Opportunities
  • 3.4. Market Trends

4. Key Insights

  • 4.1. Prevalence of Key Cardiovascular Diseases - Key Countries, 2025
  • 4.2. Number of Major Organ Transplantations, By Key Countries, 2025
  • 4.3. Pricing Analysis, Key Products, Key Countries/Regions
  • 4.4. New Product Launches, Key Players
  • 4.5. Key Industry Developments - Mergers, Acquisitions & Partnerships
  • 4.6. Impact of COVID-19 on the Market

5. Global Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 5.1. Market Analysis, Insights and Forecast - By Product Type
    • 5.1.1. Cardiopulmonary Perfusion Systems
      • 5.1.1.1. Oxygenation Systems
      • 5.1.1.2. Heart-lung Machines
      • 5.1.1.3. Cooling and Heating Devices
      • 5.1.1.4. Blood Parameter Monitoring Systems
      • 5.1.1.5. Centrifugal Blood Pump Systems
      • 5.1.1.6. Others
    • 5.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 5.1.3. Isolated Organ Perfusion Systems
  • 5.2. Market Analysis, Insights and Forecast - By Age Group
    • 5.2.1. Adults
    • 5.2.2. Pediatrics
  • 5.3. Market Analysis, Insights and Forecast - By End User
    • 5.3.1. Hospitals & ASCs
    • 5.3.2. Specialty Clinics
    • 5.3.3. Others
  • 5.4. Market Analysis, Insights and Forecast - By Region
    • 5.4.1. North America
    • 5.4.2. Europe
    • 5.4.3. Asia Pacific
    • 5.4.4. Latin America
    • 5.4.5. Middle East & Africa

6. North America Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 6.1. Market Analysis, Insights and Forecast - By Product Type
    • 6.1.1. Cardiopulmonary Perfusion Systems
      • 6.1.1.1. Oxygenation Systems
      • 6.1.1.2. Heart-lung Machines
      • 6.1.1.3. Cooling and Heating Devices
      • 6.1.1.4. Blood Parameter Monitoring Systems
      • 6.1.1.5. Centrifugal Blood Pump Systems
      • 6.1.1.6. Others
    • 6.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 6.1.3. Isolated Organ Perfusion Systems
  • 6.2. Market Analysis, Insights and Forecast - By Age Group
    • 6.2.1. Adults
    • 6.2.2. Pediatrics
  • 6.3. Market Analysis, Insights and Forecast - By End User
    • 6.3.1. Hospitals & ASCs
    • 6.3.2. Specialty Clinics
    • 6.3.3. Others
  • 6.4. Market Analysis, Insights and Forecast - By Country
    • 6.4.1. U.S.
    • 6.4.2. Canada

7. Europe Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 7.1. Market Analysis, Insights and Forecast - By Product Type
    • 7.1.1. Cardiopulmonary Perfusion Systems
      • 7.1.1.1. Oxygenation Systems
      • 7.1.1.2. Heart-lung Machines
      • 7.1.1.3. Cooling and Heating Devices
      • 7.1.1.4. Blood Parameter Monitoring Systems
      • 7.1.1.5. Centrifugal Blood Pump Systems
      • 7.1.1.6. Others
    • 7.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 7.1.3. Isolated Organ Perfusion Systems
  • 7.2. Market Analysis, Insights and Forecast - By Age Group
    • 7.2.1. Adults
    • 7.2.2. Pediatrics
  • 7.3. Market Analysis, Insights and Forecast - By End User
    • 7.3.1. Hospitals & ASCs
    • 7.3.2. Specialty Clinics
    • 7.3.3. Others
  • 7.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 7.4.1. Germany
    • 7.4.2. U.K.
    • 7.4.3. France
    • 7.4.4. Spain
    • 7.4.5. Italy
    • 7.4.6. Scandinavia
    • 7.4.7. Rest of Europe

8. Asia Pacific Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 8.1. Market Analysis, Insights and Forecast - By Product Type
    • 8.1.1. Cardiopulmonary Perfusion Systems
      • 8.1.1.1. Oxygenation Systems
      • 8.1.1.2. Heart-lung Machines
      • 8.1.1.3. Cooling and Heating Devices
      • 8.1.1.4. Blood Parameter Monitoring Systems
      • 8.1.1.5. Centrifugal Blood Pump Systems
      • 8.1.1.6. Others
    • 8.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 8.1.3. Isolated Organ Perfusion Systems
  • 8.2. Market Analysis, Insights and Forecast - By Age Group
    • 8.2.1. Adults
    • 8.2.2. Pediatrics
  • 8.3. Market Analysis, Insights and Forecast - By End User
    • 8.3.1. Hospitals & ASCs
    • 8.3.2. Specialty Clinics
    • 8.3.3. Others
  • 8.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 8.4.1. Japan
    • 8.4.2. China
    • 8.4.3. India
    • 8.4.4. Australia
    • 8.4.5. Southeast Asia
    • 8.4.6. Rest of Asia Pacific

9. Latin America Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 9.1. Market Analysis, Insights and Forecast - By Product Type
    • 9.1.1. Cardiopulmonary Perfusion Systems
      • 9.1.1.1. Oxygenation Systems
      • 9.1.1.2. Heart-lung Machines
      • 9.1.1.3. Cooling and Heating Devices
      • 9.1.1.4. Blood Parameter Monitoring Systems
      • 9.1.1.5. Centrifugal Blood Pump Systems
      • 9.1.1.6. Others
    • 9.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 9.1.3. Isolated Organ Perfusion Systems
  • 9.2. Market Analysis, Insights and Forecast - By Age Group
    • 9.2.1. Adults
    • 9.2.2. Pediatrics
  • 9.3. Market Analysis, Insights and Forecast - By End User
    • 9.3.1. Hospitals & ASCs
    • 9.3.2. Specialty Clinics
    • 9.3.3. Others
  • 9.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 9.4.1. Brazil
    • 9.4.2. Mexico
    • 9.4.3. Rest of Latin America

10. Middle East & Africa Perfusion Systems Market Analysis, Insights and Forecast, 2021-2034

  • 10.1. Market Analysis, Insights and Forecast - By Product Type
    • 10.1.1. Cardiopulmonary Perfusion Systems
      • 10.1.1.1. Oxygenation Systems
      • 10.1.1.2. Heart-lung Machines
      • 10.1.1.3. Cooling and Heating Devices
      • 10.1.1.4. Blood Parameter Monitoring Systems
      • 10.1.1.5. Centrifugal Blood Pump Systems
      • 10.1.1.6. Others
    • 10.1.2. Extracorporeal Membrane Oxygenation (ECMO)
    • 10.1.3. Isolated Organ Perfusion Systems
  • 10.2. Market Analysis, Insights and Forecast - By Age Group
    • 10.2.1. Adults
    • 10.2.2. Pediatrics
  • 10.3. Market Analysis, Insights and Forecast - By End User
    • 10.3.1. Hospitals & ASCs
    • 10.3.2. Specialty Clinics
    • 10.3.3. Others
  • 10.4. Market Analysis, Insights and Forecast - By Country/ Sub-region
    • 10.4.1. GCC
    • 10.4.2. South Africa
    • 10.4.3. Rest of Middle East & Africa

11. Competitive Analysis

  • 11.1. Global Market Share Analysis (2025)
  • 11.2. Company Profiles
    • 11.2.1. Cardinal Health
      • 11.2.1.1. Overview
      • 11.2.1.2. Services
      • 11.2.1.3. SWOT Analysis
      • 11.2.1.4. Recent Developments
      • 11.2.1.5. Strategies
      • 11.2.1.6. Financials (Based on Availability)
    • 11.2.2. Terumo Corporation
      • 11.2.2.1. Overview
      • 11.2.2.2. Services
      • 11.2.2.3. SWOT Analysis
      • 11.2.2.4. Recent Developments
      • 11.2.2.5. Strategies
      • 11.2.2.6. Financials (Based on Availability)
    • 11.2.3. Medtronic
      • 11.2.3.1. Overview
      • 11.2.3.2. Services
      • 11.2.3.3. SWOT Analysis
      • 11.2.3.4. Recent Developments
      • 11.2.3.5. Strategies
      • 11.2.3.6. Financials (Based on Availability)
    • 11.2.4. NIPRO
      • 11.2.4.1. Overview
      • 11.2.4.2. Services
      • 11.2.4.3. SWOT Analysis
      • 11.2.4.4. Recent Developments
      • 11.2.4.5. Strategies
      • 11.2.4.6. Financials (Based on Availability)
    • 11.2.5. LivaNova PLC
      • 11.2.5.1. Overview
      • 11.2.5.2. Services
      • 11.2.5.3. SWOT Analysis
      • 11.2.5.4. Recent Developments
      • 11.2.5.5. Strategies
      • 11.2.5.6. Financials (Based on Availability)
    • 11.2.6. Getinge
      • 11.2.6.1. Overview
      • 11.2.6.2. Services
      • 11.2.6.3. SWOT Analysis
      • 11.2.6.4. Recent Developments
      • 11.2.6.5. Strategies
      • 11.2.6.6. Financials (Based on Availability)
    • 11.2.7. XVIVO
      • 11.2.7.1. Overview
      • 11.2.7.2. Services
      • 11.2.7.3. SWOT Analysis
      • 11.2.7.4. Recent Developments
      • 11.2.7.5. Strategies
      • 11.2.7.6. Financials (Based on Availability)
    • 11.2.8. MicroPort Scientific Corporation
      • 11.2.8.1. Overview
      • 11.2.8.2. Services
      • 11.2.8.3. SWOT Analysis
      • 11.2.8.4. Recent Developments
      • 11.2.8.5. Strategies
      • 11.2.8.6. Financials (Based on Availability)
    • 11.2.9. TransMedics
      • 11.2.9.1. Overview
      • 11.2.9.2. Services
      • 11.2.9.3. SWOT Analysis
      • 11.2.9.4. Recent Developments
      • 11.2.9.5. Strategies
      • 11.2.9.6. Financials (Based on Availability)
    • 11.2.10. ECM Europe BV
      • 11.2.10.1. Overview
      • 11.2.10.2. Services
      • 11.2.10.3. SWOT Analysis
      • 11.2.10.4. Recent Developments
      • 11.2.10.5. Strategies
      • 11.2.10.6. Financials (Based on Availability)

List of Tables

  • Table 1: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 2: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 3: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 4: Global Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 5: Global Perfusion Systems Market Revenue (USD billion) Forecast, by Region, 2021-2034
  • Table 6: North America Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 7: North America Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 8: North America Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 9: North America Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 10: North America Perfusion Systems Market Revenue (USD billion) Forecast, By Country, 2021-2034
  • Table 11: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 12: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 13: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 14: Europe Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 15: Europe Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 16: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 17: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 18: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 19: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 20: Asia Pacific Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 21: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type, 2021-2034
  • Table 22: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 23: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 24: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 25: Latin America Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034
  • Table 26: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by Product Type 2021-2034
  • Table 27: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by Cardiopulmonary Perfusion Systems, 2021-2034
  • Table 28: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by Age Group, 2021-2034
  • Table 29: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, by End-user, 2021-2034
  • Table 30: Middle East & Africa Perfusion Systems Market Revenue (USD billion) Forecast, By Country/ Sub-region, 2021-2034

List of Figures

  • Figure 1: Global Perfusion Systems Market Revenue Breakdown (USD billion, %) by Region, 2025 & 2034
  • Figure 2: Global Perfusion Systems Market Value Share (%), by Product Type, 2025 & 2034
  • Figure 3: Global Perfusion Systems Market Value Share (%), by Age Group, 2025 & 2034
  • Figure 4: Global Perfusion Systems Market Value Share (%), by End-user, 2025 & 2034
  • Figure 5: Global Perfusion Systems Market Value Share (%), by Region, 2025 & 2034
  • Figure 6: North America Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 7: North America Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 8: North America Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 9: North America Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 10: North America Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 11: North America Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 12: North America Perfusion Systems Market Value (USD billion), By Country, 2025 & 2034
  • Figure 13: North America Perfusion Systems Market Value Share (%), By Country, 2025
  • Figure 14: Europe Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 15: Europe Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 16: Europe Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 17: Europe Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 18: Europe Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 19: Europe Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 20: Europe Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 21: Europe Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 22: Asia Pacific Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 23: Asia Pacific Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 24: Asia Pacific Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 25: Asia Pacific Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 26: Asia Pacific Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 27: Asia Pacific Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 28: Asia Pacific Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 29: Asia Pacific Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 30: Latin America Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 31: Latin America Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 32: Latin America Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 33: Latin America Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 34: Latin America Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 35: Latin America Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 36: Latin America Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 37: Latin America Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 38: Middle East & Africa Perfusion Systems Market Value (USD billion), by Product Type, 2025 & 2034
  • Figure 39: Middle East & Africa Perfusion Systems Market Value Share (%), by Product Type, 2025
  • Figure 40: Middle East & Africa Perfusion Systems Market Value (USD billion), by Age Group, 2025 & 2034
  • Figure 41: Middle East & Africa Perfusion Systems Market Value Share (%), by Age Group, 2025
  • Figure 42: Middle East & Africa Perfusion Systems Market Value (USD billion), by End-user, 2025 & 2034
  • Figure 43: Middle East & Africa Perfusion Systems Market Value Share (%), by End-user, 2025
  • Figure 44: Middle East & Africa Perfusion Systems Market Value (USD billion), By Country/ Sub-region, 2025 & 2034
  • Figure 45: Middle East & Africa Perfusion Systems Market Value Share (%), By Country/ Sub-region, 2025
  • Figure 46: Global Perfusion Systems Market Share (%), By Company, 2025